JP2024505197A5 - - Google Patents
Info
- Publication number
- JP2024505197A5 JP2024505197A5 JP2023544528A JP2023544528A JP2024505197A5 JP 2024505197 A5 JP2024505197 A5 JP 2024505197A5 JP 2023544528 A JP2023544528 A JP 2023544528A JP 2023544528 A JP2023544528 A JP 2023544528A JP 2024505197 A5 JP2024505197 A5 JP 2024505197A5
- Authority
- JP
- Japan
- Prior art keywords
- neuron
- composition
- ligand
- item
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163141121P | 2021-01-25 | 2021-01-25 | |
| US202163141124P | 2021-01-25 | 2021-01-25 | |
| US63/141,124 | 2021-01-25 | ||
| US63/141,121 | 2021-01-25 | ||
| US202163285929P | 2021-12-03 | 2021-12-03 | |
| US63/285,929 | 2021-12-03 | ||
| PCT/US2022/013658 WO2022159871A1 (en) | 2021-01-25 | 2022-01-25 | Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505197A JP2024505197A (ja) | 2024-02-05 |
| JP2024505197A5 true JP2024505197A5 (https=) | 2025-02-03 |
Family
ID=82549286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023544528A Pending JP2024505197A (ja) | 2021-01-25 | 2022-01-25 | 焦点てんかんおよび神経因性疼痛を処置するためのアデノ随伴ウイルスカプシドおよび操作されたリガンド依存性イオンチャネル |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240108760A1 (https=) |
| EP (1) | EP4281551A4 (https=) |
| JP (1) | JP2024505197A (https=) |
| KR (1) | KR20230149299A (https=) |
| AU (1) | AU2022211055A1 (https=) |
| CA (1) | CA3205877A1 (https=) |
| IL (1) | IL304511A (https=) |
| MX (1) | MX2023008738A (https=) |
| WO (1) | WO2022159871A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025188847A1 (en) * | 2024-03-07 | 2025-09-12 | The Texas A&M University System | Method for treating epilepsy |
| WO2025230969A1 (en) * | 2024-05-02 | 2025-11-06 | 4D Molecular Therapeutics Inc. | Aav variants with improved cns tropism and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2345731B1 (en) * | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| US20170007720A1 (en) * | 2014-02-21 | 2017-01-12 | University Of Florida Research Foundation, Inc. | Methods and compositions for gene delivery to on bipolar cells |
| AU2016324317A1 (en) * | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| WO2017214442A1 (en) * | 2016-06-08 | 2017-12-14 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome |
| US10538571B2 (en) * | 2017-11-27 | 2020-01-21 | Coda Biotherapeutics, Inc. | Compositions and methods for neurological diseases |
| EP3810775A1 (en) * | 2018-06-21 | 2021-04-28 | The Board Of Regents Of The University Of Texas System | Correction of dystrophin exon 43, exon 45, or exon 52 deletions in duchenne muscular dystrophy |
-
2022
- 2022-01-25 MX MX2023008738A patent/MX2023008738A/es unknown
- 2022-01-25 AU AU2022211055A patent/AU2022211055A1/en active Pending
- 2022-01-25 US US18/273,867 patent/US20240108760A1/en active Pending
- 2022-01-25 KR KR1020237028925A patent/KR20230149299A/ko active Pending
- 2022-01-25 EP EP22743368.7A patent/EP4281551A4/en active Pending
- 2022-01-25 JP JP2023544528A patent/JP2024505197A/ja active Pending
- 2022-01-25 CA CA3205877A patent/CA3205877A1/en active Pending
- 2022-01-25 WO PCT/US2022/013658 patent/WO2022159871A1/en not_active Ceased
-
2023
- 2023-07-17 IL IL304511A patent/IL304511A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024505197A5 (https=) | ||
| JP2022141670A5 (https=) | ||
| CA2407309C (en) | Dna sequences encoding dystrophin minigenes and methods of use thereof | |
| JP2023504314A5 (https=) | ||
| RU2018112506A (ru) | Лечение пигментного ретинита | |
| JP2021534809A (ja) | Ａａｖカプシドの向性の再指向化 | |
| JP2018508519A5 (https=) | ||
| JP2023535121A5 (https=) | ||
| JP2022531809A5 (https=) | ||
| JP7291423B2 (ja) | ＡＩＭＰ２－ＤＸ２およびｍｉＲ－１４２の標的核酸を含むベクター、ならびにその使用 | |
| JP2021525245A5 (https=) | ||
| JP2022545226A5 (https=) | ||
| RU2019126509A (ru) | Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе | |
| JP2023537980A5 (https=) | ||
| JP2023534037A5 (https=) | ||
| RU2018132517A (ru) | Aav-idua вектор для лечения ассоциированной с mps i слепоты | |
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| JP2020500526A5 (https=) | ||
| MX2023012410A (es) | Metodos para tratar enfermedades oculares usando variantes de aav2 que codifican aflibercept. | |
| IL300294A (en) | Gene therapy using nucleic acid constructs containing methyl CPG-binding protein 2 (MECP2) promoter sequences | |
| CN121219325A (zh) | 一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用 | |
| JP2022533451A5 (https=) | ||
| JP2020533968A (ja) | 組換えアデノ随伴ベクター | |
| JP2021534206A (ja) | Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置 | |
| CA3197321A1 (en) | Neurod1 vector |